AMERICAN INTERNATIONAL GROUP, INC. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$68,000
-43.8%
104,071
-6.6%
0.00%
-100.0%
Q4 2021$121,000
-42.1%
111,397
-2.9%
0.00%0.0%
Q3 2021$209,000
-32.6%
114,729
-2.3%
0.00%0.0%
Q2 2021$310,000
-30.6%
117,455
-5.5%
0.00%
-50.0%
Q1 2021$447,000
+43.3%
124,248
+0.3%
0.00%
+100.0%
Q4 2020$312,000
-2.8%
123,920
-2.8%
0.00%
-50.0%
Q3 2020$321,000
-25.0%
127,477
-2.2%
0.00%0.0%
Q2 2020$428,000
+59.1%
130,375
+18.9%
0.00%
+100.0%
Q1 2020$269,000
-43.2%
109,629
+9.1%
0.00%
-50.0%
Q4 2019$474,000
+9.2%
100,512
-0.8%
0.00%0.0%
Q3 2019$434,000
-27.1%
101,359
-0.7%
0.00%0.0%
Q2 2019$595,000
+84.2%
102,064
+21.6%
0.00%
+100.0%
Q1 2019$323,000
+99.4%
83,902
-3.1%
0.00%0.0%
Q4 2018$162,000
-41.9%
86,623
-0.8%
0.00%0.0%
Q3 2018$279,000
+7.7%
87,289
+1.8%
0.00%0.0%
Q2 2018$259,000
-21.3%
85,715
+2.1%
0.00%0.0%
Q1 2018$329,000
-10.1%
83,989
-5.1%
0.00%0.0%
Q4 2017$366,000
-32.3%
88,506
+0.5%
0.00%
-50.0%
Q3 2017$541,000
+6.7%
88,088
+8.1%
0.00%0.0%
Q2 2017$507,000
+6.7%
81,502
+8.9%
0.00%0.0%
Q1 2017$475,000
+27.0%
74,843
+7.1%
0.00%
+100.0%
Q4 2016$374,000
-99.9%
69,892
-0.3%
0.00%
-50.0%
Q3 2016$394,505,000
+2.7%
70,072
+0.2%
0.00%0.0%
Q2 2016$384,108,000
-39.8%
69,965
-18.7%
0.00%0.0%
Q1 2016$638,000,000
-10.8%
86,1100.0%0.00%
-33.3%
Q4 2015$715,000,000
+81335.1%
86,110
-11.6%
0.00%
-25.0%
Q3 2015$878,000
-99.9%
97,420
+15.2%
0.00%0.0%
Q2 2015$1,014,480,000
+34.2%
84,540
+20.5%
0.00%
+33.3%
Q1 2015$755,774,000
+109.8%
70,174
-1.2%
0.00%
+50.0%
Q4 2014$360,198,000
+86.7%
71,045
-2.8%
0.00%
+100.0%
Q3 2014$192,886,000
-34.5%
73,063
-0.1%
0.00%0.0%
Q2 2014$294,605,000
-13.9%
73,103
-2.1%
0.00%
-50.0%
Q1 2014$342,108,000
+7.4%
74,696
+1.8%
0.00%0.0%
Q4 2013$318,482,000
+29.1%
73,383
+17.4%
0.00%
+100.0%
Q3 2013$246,696,000
+85.4%
62,499
-1.2%
0.00%0.0%
Q2 2013$133,082,00063,2890.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2015
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders